News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
828,884 Results
Type
Article (75201)
Company Profile (663)
Press Release (752993)
Multimedia
Podcasts (158)
Webinars (26)
Section
Business (227809)
Career Advice (3730)
Deals (39372)
Drug Delivery (133)
Drug Development (89591)
Employer Resources (201)
FDA (18002)
Job Trends (17189)
News (388579)
Policy (38934)
Tag
Academia (3002)
Academic (1)
Accelerated approval (17)
Adcomms (35)
Allergies (119)
Alliances (56129)
ALS (137)
Alzheimer's disease (1648)
Antibody-drug conjugate (ADC) (206)
Approvals (17998)
Artificial intelligence (424)
Autoimmune disease (48)
Automation (23)
Bankruptcy (404)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (150)
Biotechnology (441)
Bladder cancer (118)
Brain cancer (47)
Breast cancer (437)
Cancer (3543)
Cardiovascular disease (312)
Career advice (3186)
Career pathing (36)
CAR-T (231)
CDC (51)
Cell therapy (616)
Cervical cancer (29)
Clinical research (73767)
Collaboration (1293)
Company closure (4)
Compensation (868)
Complete response letters (51)
COVID-19 (2940)
CRISPR (78)
C-suite (514)
Cystic fibrosis (130)
Data (3838)
Decentralized trials (2)
Denatured (55)
Depression (100)
Diabetes (427)
Diagnostics (7044)
Digital health (28)
Diversity (11)
Diversity, equity & inclusion (49)
Drug discovery (188)
Drug pricing (168)
Drug shortages (36)
Duchenne muscular dystrophy (183)
Earnings (95883)
Editorial (53)
Employer branding (25)
Employer resources (169)
Events (131317)
Executive appointments (958)
FDA (20250)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (4)
Frontotemporal dementia (11)
Funding (1133)
Gene editing (165)
Generative AI (36)
Gene therapy (495)
GLP-1 (1000)
Government (5302)
Grass and pollen (7)
Guidances (334)
Healthcare (20914)
HIV (47)
Huntington's disease (34)
IgA nephropathy (52)
Immunology and inflammation (226)
Immuno-oncology (19)
Indications (47)
Infectious disease (3159)
Inflammatory bowel disease (179)
Inflation Reduction Act (13)
Influenza (86)
Intellectual property (168)
Interviews (729)
IPO (17851)
IRA (59)
Job creations (4997)
Job search strategy (2595)
Kidney cancer (14)
Labor market (70)
Layoffs (625)
Leadership (31)
Legal (9945)
Liver cancer (90)
Longevity (12)
Lung cancer (511)
Lymphoma (251)
Machine learning (22)
Management (65)
Manufacturing (567)
MASH (121)
Medical device (14812)
Medtech (14830)
Mergers & acquisitions (22341)
Metabolic disorders (1086)
Multiple sclerosis (120)
NASH (23)
Neurodegenerative disease (184)
Neuropsychiatric disorders (50)
Neuroscience (2554)
NextGen: Class of 2025 (7640)
Non-profit (5093)
Now hiring (54)
Obesity (542)
Opinion (304)
Ovarian cancer (114)
Pain (156)
Pancreatic cancer (147)
Parkinson's disease (214)
Partnered (25)
Patents (387)
Patient recruitment (272)
Peanut (57)
People (64861)
Pharmaceutical (133)
Pharmacy benefit managers (25)
Phase I (22779)
Phase II (32183)
Phase III (24233)
Pipeline (2488)
Policy (281)
Postmarket research (3258)
Preclinical (10067)
Press Release (72)
Prostate cancer (175)
Psychedelics (49)
Radiopharmaceuticals (280)
Rare diseases (605)
Real estate (7166)
Recruiting (76)
Regulatory (26998)
Reports (64)
Research institute (2672)
Resumes & cover letters (580)
Rett syndrome (12)
RNA editing (15)
RSV (64)
Schizophrenia (121)
Series A (190)
Series B (142)
Service/supplier (26)
Sickle cell disease (77)
Special edition (25)
Spinal muscular atrophy (167)
Sponsored (40)
Startups (4222)
State (2)
Stomach cancer (17)
Supply chain (94)
Tariffs (83)
The Weekly (101)
Vaccines (1010)
Venture capital (63)
Weight loss (377)
Women's health (54)
Worklife (21)
Date
Today (6)
Last 7 days (532)
Last 30 days (2326)
Last 365 days (33064)
2025 (23448)
2024 (37898)
2023 (42567)
2022 (53927)
2021 (58723)
2020 (57663)
2019 (51302)
2018 (39084)
2017 (36829)
2016 (37739)
2015 (43730)
2014 (38413)
2013 (34388)
2012 (36287)
2011 (36403)
2010 (35833)
Location
Africa (1198)
Alabama (78)
Alaska (7)
Arizona (277)
Arkansas (14)
Asia (49332)
Australia (8458)
California (8952)
Canada (2718)
China (847)
Colorado (379)
Connecticut (398)
Delaware (241)
Europe (111593)
Florida (1317)
Georgia (305)
Hawaii (3)
Idaho (66)
Illinois (768)
India (46)
Indiana (433)
Iowa (19)
Japan (269)
Kansas (122)
Kentucky (35)
Louisiana (20)
Maine (75)
Maryland (1220)
Massachusetts (6729)
Michigan (294)
Minnesota (543)
Mississippi (4)
Missouri (113)
Montana (32)
Nebraska (26)
Nevada (102)
New Hampshire (75)
New Jersey (2469)
New Mexico (32)
New York (2439)
North Carolina (1359)
North Dakota (10)
Northern California (3989)
Ohio (279)
Oklahoma (19)
Oregon (47)
Pennsylvania (1862)
Puerto Rico (18)
Rhode Island (44)
South America (1567)
South Carolina (45)
South Dakota (1)
Southern California (3410)
Tennessee (141)
Texas (1390)
United States (33106)
Utah (267)
Virginia (237)
Washington D.C. (82)
Washington State (766)
West Virginia (4)
Wisconsin (90)
828,884 Results for "sumitomo pharmaceuticals co ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Ocugen, Inc. and Kwangdong Pharmaceutical Co., Ltd. Complete License Agreement of OCU400 Modifier Gene Therapy for Retinitis Pigmentosa in Korea
September 15, 2025
·
5 min read
Press Releases
Amphastar Pharmaceuticals Bolsters Proprietary Pipeline Through Exclusive Licensing Agreement with Nanjing Anji Biotechnology Co., Ltd.
August 12, 2025
·
6 min read
Press Releases
NKGen Biotech, Inc. Announces Completion of NKMax Co., Ltd. Acquisition; Gains Full Control of Global Manufacturing and Intellectual Property Assets
September 10, 2025
·
8 min read
Press Releases
Sumitomo Pharma America Announces that the European Medicines Agency Has Granted Orphan Drug Designation to Nuvisertib (TP-3654) for the Treatment of Myelofibrosis
July 30, 2025
·
4 min read
Business
RevolKa Ltd.: Announcement of Milestone Achievement in the Collaborative Research with Sumitomo Pharma Co., Ltd.
RevolKa Ltd., a venture-backed biotech company providing a game-changing protein engineering technology platform is pleased to announce the successful completion of the collaborative drug discovery project with Sumitomo Pharma Co., Ltd. for rare diseases within the contractually agreed time frame.
June 23, 2023
·
3 min read
Press Releases
CORRECTION FROM SOURCE: Faron Pharmaceuticals Ltd: Half-Year Financial Results 1 January - 30 June 2025
September 15, 2025
·
18 min read
Press Releases
Sumitomo Pharma America Announces that Nuvisertib (TP-3654) Has Received FDA Fast Track Designation for the Treatment of Myelofibrosis
June 13, 2025
·
5 min read
Press Releases
Sumitomo Pharma America enters into a Cooperative Research and Development Agreement with the National Cancer Institute to Advance Clinical Understanding of Enzomenib
April 14, 2025
·
5 min read
Press Releases
Univar Solutions and Shandong Head Group Co., Ltd. Establish Exclusive European Partnership to Enhance Supply of Cellulose Ethers and Pharmaceutical Excipients
May 22, 2025
·
7 min read
Press Releases
Medicus Pharma Ltd. Completes Acquisition of Antev Limited
Antev is developing Teverelix, a next generation GnRH Antagonist, as a first in class market product for Acute Urinary Retention (AURr) and high CV risk Prostate Cancer collecting representing ~US$6 billion in potential market opportunityPatrick J. Mahaffy, a veteran pharma executive and the former Chairman of Antev, appointed to Medicus Board of Directors
September 2, 2025
·
10 min read
1 of 82,889
Next
